Skip to main content
. 2015 Aug 16;36(11):1275–1283. doi: 10.1093/carcin/bgv118

Table 3.

Association between the rs588765-rs16969968 haplotype and risk of lung cancer

Haplotype Control Case Crude Adjusteda
N % N % OR (95%CI) P OR (95% CI) P
Discovery
 CG/CG 122 6.25 71 3.91 1 1
 CG/TG 383 19.61 227 12.51 1.02 (0.73–1.42) 0.91 0.96 (0.66–1.40) 0.83
 TG/TG 245 12.54 216 11.91 1.52 (1.07–2.14) 0.02 1.50 (1.01–2.23) 0.04
 TG/CA 536 27.44 544 29.99 1.74 (1.27–2.39) 0.001 1.75 (1.22–2.50) 0.002
 CG/CA 381 19.51 360 19.85 1.62 (1.17–2.25) 0.004 1.49 (1.02–2.17) 0.04
 CA/CA 286 14.64 396 21.83 2.38 (1.71–3.31) <0.0001 2.12 (1.46–3.07) <0.0001
Replication
 CG/CG 208 5.85 115 3.86 1 1
 CG/TG 700 19.70 474 15.89 1.23 (0.95–1.58) 0.12 1.14 (0.86–0.86) 0.36
 TG/TG 646 18.18 499 16.73 1.40 (1.08–1.81) 0.01 1.26 (0.96–1.66) 0.09
 TG/CA 1053 29.64 940 31.51 1.62 (1.27–2.06) 0.0001 1.43 (1.10–1.85) 0.01
 CG/CA 546 15.37 465 15.59 1.54 (1.19–2.00) 0.001 1.40 (1.07–1.85) 0.01
 CA/CA 400 11.26 490 16.43 2.22 (1.70–2.88) <0.0001 2.01 (1.51–2.67) <0.0001

aAdjusted for age at diagnosis/interview, sex, smoking status and smoking pack-years, the significant PCs.